Kelsey L. Hickey

Kelsey L. Hickey

Auto-generated profile, based on publicly available information

Kelsey L. Hickey

Department of Cell Biology, Harvard Medical School

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Molecular Cell
Verified
Journal Article
Closed access
KHKelsey L. Hickey
Kelsey L. Hickey
KDKimberley Dickson
Kimberley Dickson
JCJ. Zachery Cogan
J. Zachery Cogan
JRJoseph M. Replogle
Joseph M. Replogle
MSMichael Schoof
Michael Schoof
KKKamena K. Kostova
Kamena K. Kostova

28 July 2017 in Science
Verified
Journal Article
Closed access
PDF file
KKKamena K. Kostova
Kamena K. Kostova
KHKelsey L. Hickey
Kelsey L. Hickey
BOBeatriz A. Osuna
Beatriz A. Osuna
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
AFAdam Frost
Adam Frost
JWJonathan S. Weissman
Jonathan S. Weissman
A tale of CAT tails: When protein translation fails, the incomplete nascent polypeptide is targeted for degradation by the highly conserved ribosome-associated quality control complex (RQC). Mutations in RQC components lead to stress at the cellular level and neurodegeneration at the organismal level. Recent studies have shown that RQC tags partially synthesize proteins with C-terminal alanine and threonine (CAT) tails in an unusual elongation reaction. Working in yeast, Kostova et al. elucidated the role of this process. CAT-tailing is a fail-safe mechanism to ensure the degradation of partially synthesized proteins. The elongation process appears to “push” lysines out of the ribosome exit tunnel, which allows them to be marked by ubiquitin degradation signals. Science , this issue p. 414

5 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KHKelsey L. Hickey
Kelsey L. Hickey
APAlexandra Panov
Alexandra Panov
EWEnya Miguel Whelan
Enya Miguel Whelan
TSTillman Schäfer
Tillman Schäfer
AMArda Mizrak
Arda Mizrak
JHJ. Wade Harper
J. Wade Harper
A hallmark of neurodegenerative diseases (NDs) is the progressive loss of proteostasis, leading to the accumulation of misfolded proteins or protein aggregates, with subsequent cytotoxicity. To combat this toxicity, cells have evolved degradation pathways (ubiquitin–proteasome system and autophagy) that detect and degrade misfolded proteins. However, studying the underlying cellular pathways and mechanisms has remained a challenge, as formation of many types of protein aggregates is asynchronous, with individual cells displaying distinct kinetics, thereby hindering rigorous time-course studies. Here, we merge a kinetically tractable and synchronous agDD-GFP system for aggregate formation with targeted gene knockdowns, to uncover degradation mechanisms used in response to acute aggregate formation. We find that agDD-GFP forms amorphous aggregates by cryo-electron tomography at both early and late stages of aggregate formation. Aggregate turnover occurs in a proteasome-dependent mechanism in a manner that is dictated by cellular aggregate burden, with no evidence of the involvement of autophagy. Lower levels of misfolded agDD-GFP, enriched in oligomers, utilizes UBE3C-dependent proteasomal degradation in a pathway that is independent of RPN13 ubiquitylation by UBE3C. Higher aggregate burden activates the NRF1 transcription factor to increase proteasome subunit transcription and subsequent degradation capacity of cells. Loss or gain of NRF1 function alters the turnover of agDD-GFP under conditions of high aggregate burden. Together, these results define the role of UBE3C in degradation of this class of misfolded aggregation-prone proteins and reveals a role for NRF1 in proteostasis control in response to widespread protein aggregation.

7 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKelsey L. Hickey
Kelsey L. Hickey
SSSharan Swarup
Sharan Swarup
ISIan R. Smith
Ian R. Smith
JPJulia C. Paoli
Julia C. Paoli
JPJoao A. Paulo
Joao A. Paulo
JHJ. Wade Harper
J. Wade Harper
During nutrient stress, macroautophagy is employed to degrade cellular macromolecules, thereby providing biosynthetic building blocks while simultaneously remodeling the proteome. While the machinery responsible for initiation of macroautophagy is well characterized, our understanding of the extent to which individual proteins, protein complexes and organelles are selected for autophagic degradation, and the underlying targeting mechanisms is limited. Here, we use orthogonal proteomic strategies to provide a global molecular inventory of autophagic cargo during nutrient stress in mammalian cell lines. Through prioritization of autophagic cargo, we identify a heterodimeric pair of membrane-embedded proteins, YIPF3 and YIPF4, as receptors for Golgiphagy. During nutrient stress, YIPF4 is mobilized into ATG8-positive vesicles that traffic to lysosomes as measured via Golgiphagy flux reporters in a process that requires the VPS34 and ULK1-FIP200 arms of the autophagy system. Cells lacking YIPF3 or YIPF4 are selectively defective in elimination of Golgi membrane proteins during nutrient stress. By merging absolute protein abundance with autophagic turnover, we create a global protein census describing how autophagic degradation maps onto protein abundance and subcellular localization. Our results, available via an interactive web tool, reveal that autophagic turnover prioritizes membrane-bound organelles (principally Golgi and ER) for proteome remodeling during nutrient stress. One-Sentence Summary During nutrient stress, macroautophagy uses organelle-phagy receptors to prioritize recycling of Golgi and ER membrane proteins.

1 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKelsey L. Hickey
Kelsey L. Hickey
APAlexandra Panov
Alexandra Panov
EWEnya Miguel Whelan
Enya Miguel Whelan
TSTillman Schäfer
Tillman Schäfer
AMArda Mizrak
Arda Mizrak
JHJ. Wade Harper
J. Wade Harper
A hallmark of neurodegenerative diseases is the progressive loss of proteostasis, leading to the accumulation of misfolded proteins or protein aggregates, with subsequent cytotoxicity. To combat this toxicity, cells have evolved degradation pathways (ubiquitin-proteasome system and autophagy) that detect and degrade misfolded proteins. However, studying the underlying cellular pathways and mechanisms has remained a challenge, as formation of many types of protein aggregates is asynchronous, with individual cells displaying distinct kinetics, thereby hindering rigorous time-course studies. Here, we merge a kinetically tractable and synchronous agDD-GFP system for aggregate formation with targeted gene knockdowns, to uncover degradation mechanisms used in response to acute aggregate formation. We find that agDD-GFP forms amorphous aggregates by cryo-electron tomography at both early and late stages of aggregate formation. Aggregate turnover occurs in a proteasome-dependent mechanism in a manner that is dictated by cellular aggregate burden, with no evidence of the involvement of autophagy. Lower levels of misfolded agDD-GFP, enriched in oligomers, utilizes UBE3C-dependent proteasomal degradation in a pathway that is independent of RPN13 ubiquitylation by UBE3C. Higher aggregate burden activates the NRF1 transcription factor to increase proteasome subunit transcription, and subsequent degradation capacity of cells. Loss or gain of NRF1 function alters the turnover of agDD-GFP under conditions of high aggregate burden. Together, these results define the role of UBE3C in degradation of this class of misfolded aggregation-prone proteins and reveals a role for NRF1 in proteostasis control in response to widespread protein aggregation. Significance Statement A hallmark of neurodegenerative diseases such as Parkinson’s Disease is the progressive loss of proteostasis, leading to conversion of proteins from productive folding pathways to populate aggregation-prone misfolded (non-native or intermediate) states. To combat this toxicity, cells have evolved degradation pathways (ubiquitin-proteasome system and autophagy) that detect and degrade misfolded proteins. Here, we find that aggregation burden dictates the activation of proteasome-dependent quality control pathways. Initial misfolded proteins, enriched in oligomers, utilize UBE3C-dependent proteasomal degradation, while higher aggregation levels, enriched in larger insoluble structures, activate the NRF1 transcription factor to increase proteasome subunit transcription, and subsequent degradation capacity of cells. The role of UBE3C and NRF1 in aggregation clearance may provide therapeutic targets aimed to preventing neurodegenerative disease.

17 October 2024
Verified
Preprint
Open access
PDF file
HJHarper Jw
Harper Jw
KHKelsey Hickey
Kelsey Hickey
This protocol describes methods for visualization of agDD-GFP aggregates and NRF1 by fluorescence imaging and immunofluorescence, respectively.